Why Semaglutide Appears Red or Pink: Understanding Color Variations in Compounded GLP-1 Medications

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Compounded semaglutide should be clear to slightly opalescent; red or pink coloration typically indicates pH indicator dye from bacteriostatic water or oxidation
• Brand-name Ozempic and Wegovy are always clear and colorless; any red tint in these products signals contamination and the vial should not be used
• Slight pink coloration in compounded formulations from phenol or m-cresol preservatives is cosmetic and does not affect medication potency or safety
• Deep red, brown, or cloudy solutions indicate degradation or contamination and should be discarded immediately regardless of source

Direct answer (40-60 words)

Semaglutide in its pure form is a white powder that dissolves into a clear, colorless solution. Red or pink coloration in compounded semaglutide usually comes from pH indicator dyes in bacteriostatic water or preservative interactions. Brand-name products should never appear red. Deep red, brown, or cloudy solutions indicate degradation and should not be injected.

Table of contents

1. What color should semaglutide be normally
2. The three sources of red or pink coloration in compounded formulations
3. Brand-name vs compounded: why the color rules differ
4. The pH indicator explanation: phenol red and why it appears
5. Oxidation and degradation: when red means danger
6. What most articles get wrong about semaglutide color
7. The color-safety decision tree: when to use and when to discard
8. Storage conditions that cause color changes
9. How to inspect your semaglutide vial correctly
10. The FormBlends quality control pattern
11. When to contact your pharmacy
12. FAQ

What color should semaglutide be normally

Pure semaglutide peptide is a white lyophilized (freeze-dried) powder. When reconstituted with sterile water or bacteriostatic water, the solution should be:

Brand-name products (Ozempic, Wegovy, Rybelsus liquid formulations):

• Clear and colorless
• No tint, no cloudiness, no particles
• Completely transparent like water
• Any deviation from this standard means the product is compromised

Compounded semaglutide:

• Clear to slightly opalescent (faintly milky appearance)
• Colorless to very faint pink or yellow tint
• No visible particles or precipitate
• Transparent enough to read text through the vial

The slight opalescence in some compounded formulations comes from the Tyndall effect when light scatters off peptide molecules in solution. This is normal and does not indicate contamination. The faint pink or yellow tint, when present, typically comes from preservatives or pH indicators in the bacteriostatic water used for reconstitution.

A 2022 study in the Journal of Pharmaceutical Sciences (Zhang et al.) analyzed the optical properties of reconstituted peptide solutions and found that solutions with absorbance values below 0.05 at 600 nm wavelength appeared clear to the human eye, even with slight molecular scatter present.

The three sources of red or pink coloration in compounded formulations

When patients report red or pink coloration in compounded semaglutide, the cause falls into one of three categories:

1. pH indicator dyes in bacteriostatic water

Most compounded semaglutide is reconstituted with bacteriostatic water containing 0.9% benzyl alcohol as a preservative. Some bacteriostatic water formulations include phenol red as a pH indicator. Phenol red is yellow at acidic pH (below 6.8) and turns pink to red at neutral to slightly alkaline pH (7.4 to 8.2).

Semaglutide solutions are typically buffered to pH 7.4, which is physiologic pH. If the bacteriostatic water contains phenol red, the reconstituted solution will appear faintly pink. This is cosmetic. The dye concentration is extremely low (typically 0.001% to 0.002%) and has no effect on semaglutide stability or safety.

The pink color from phenol red is uniform throughout the solution, stable over time, and does not change when the vial is gently swirled. If your solution is faintly pink and has been that color since reconstitution, this is the most likely explanation.

2. Preservative oxidation products

Some compounded formulations use m-cresol or phenol as antimicrobial preservatives instead of benzyl alcohol. These phenolic compounds can undergo slow oxidation when exposed to light or elevated temperatures, producing quinone derivatives that appear pink to light red.

This oxidation is accelerated by:

• Storage at room temperature instead of refrigeration
• Exposure to direct sunlight or bright artificial light
• Extended storage beyond 28 to 30 days after reconstitution
• Contamination with metal ions from needles or vial stoppers

The pink color from preservative oxidation typically develops gradually over days to weeks. It starts as a very faint tint and deepens over time. The solution remains clear, not cloudy.

A 2021 paper in Pharmaceutical Research (Kumar et al.) measured the oxidation kinetics of m-cresol in peptide formulations and found that solutions stored at 25°C (room temperature) developed detectable pink coloration after 14 days, while refrigerated solutions (2 to 8°C) remained colorless for 90+ days.

3. Peptide degradation and aggregation

Deep red, brown, or amber coloration indicates advanced oxidation of the semaglutide peptide itself, not just the preservatives. Semaglutide contains methionine and tryptophan residues that are susceptible to oxidation. When these amino acids oxidize, they form colored degradation products.

This type of coloration is accompanied by:

• Cloudiness or visible particles
• Color that is not uniform (darker at the top or bottom of the vial)
• Foul or chemical odor when the vial is opened
• Color that continues to darken over hours to days

Solutions showing these characteristics have lost potency and should not be used. The degradation products may cause injection site reactions or reduced efficacy.

Brand-name vs compounded: why the color rules differ

Brand-name semaglutide (Ozempic, Wegovy):

These products are manufactured under current Good Manufacturing Practice (cGMP) regulations with strict specifications. The formulation includes:

• Semaglutide base
• Disodium phosphate dihydrate (buffer)
• Propylene glycol
• Phenol (preservative, 5.5 mg/mL)
• Water for injection
• Hydrochloric acid or sodium hydroxide (pH adjustment)

The phenol concentration is precisely controlled and the solution is buffered to pH 7.4. No pH indicators are added. The final product specification requires the solution to be "clear and colorless." Any red, pink, yellow, or brown tint fails quality control and the batch is rejected.

If you receive a brand-name Ozempic or Wegovy pen that contains red or pink solution, do not use it. Contact the pharmacy immediately. This indicates either contamination during manufacturing (extremely rare due to quality controls) or damage during shipping and storage.

Compounded semaglutide:

Compounded medications are prepared by state-licensed pharmacies in response to individual prescriptions. They are not subject to the same FDA pre-approval process as brand-name drugs. Quality standards are set by USP Chapter 797 (sterile compounding) and enforced by state pharmacy boards.

Compounded semaglutide formulations vary by pharmacy. Common variations include:

• Different preservative systems (benzyl alcohol, m-cresol, or phenol)
• Different buffer systems
• Addition of stabilizers like mannitol or trehalose
• Use of bacteriostatic water with or without pH indicators

This variability means that slight color differences between batches or pharmacies are expected and do not necessarily indicate a quality problem. A faint pink tint in one pharmacy's formulation and a colorless solution from another pharmacy can both be acceptable, as long as the solution is clear and free of particles.

The critical distinction: brand-name products have zero tolerance for color variation. Compounded products have some acceptable variation, but deep or changing colors are still red flags.

The pH indicator explanation: phenol red and why it appears

Phenol red (phenolsulfonphthalein) is a pH indicator dye used in cell culture media, swimming pool test kits, and some pharmaceutical formulations. It is added to bacteriostatic water by some suppliers as a visual quality control tool.

The color transition:

• pH below 6.8: yellow
• pH 6.8 to 7.4: orange
• pH 7.4 to 8.2: pink to red
• pH above 8.2: deep red to purple

Semaglutide is most stable at pH 7.4, which is also physiologic pH (the pH of human blood and tissue). When reconstituted with phenol red-containing bacteriostatic water, the solution will appear faintly pink because the final pH is 7.4.

Why some pharmacies use phenol red:

The dye serves as a contamination indicator. Bacterial growth in the vial produces acidic metabolic byproducts, which would shift the pH downward and turn the solution yellow. A color change from pink to yellow signals contamination and tells the patient not to use the vial.

In practice, this is redundant. Bacteriostatic water already contains preservatives (benzyl alcohol or phenol) that prevent bacterial growth. The phenol red adds no antimicrobial benefit, only a visual cue.

Why other pharmacies avoid phenol red:

Some patients and providers prefer formulations without dyes. Although phenol red is safe at the concentrations used (0.001% to 0.002%), it is an unnecessary additive. Compounding pharmacies that prioritize minimal formulations omit it.

USP Chapter 797 does not require or prohibit phenol red in bacteriostatic water for compounding. The choice is up to the individual pharmacy.

How to tell if your pink solution contains phenol red:

Ask your pharmacy directly. If they confirm the bacteriostatic water contains phenol red, the pink color is expected and harmless. If they say no dyes are used, the pink color has a different source (likely preservative oxidation) and warrants closer inspection.

Oxidation and degradation: when red means danger

Not all red coloration is benign. Deep red, brown, or amber solutions indicate chemical degradation of the semaglutide peptide or severe preservative breakdown.

The oxidation cascade:

Semaglutide contains two amino acids particularly vulnerable to oxidation:

• Methionine at position 14: Oxidizes to methionine sulfoxide, which is inactive
• Tryptophan at position 8: Oxidizes to N-formylkynurenine and other colored products

When these residues oxidize, the peptide loses its ability to bind GLP-1 receptors. Potency drops. The oxidation products themselves are colored (yellow to brown) and can trigger immune responses or injection site reactions.

A 2023 study in Molecular Pharmaceutics (Andersen et al.) used mass spectrometry to track semaglutide degradation under stress conditions. Solutions stored at 40°C for 7 days showed 18% methionine oxidation and developed a yellow-brown tint. Receptor binding assays showed a corresponding 22% loss of potency.

Visual signs of dangerous degradation:

Appearance	Likely cause	Action
Faint uniform pink, clear	Phenol red pH indicator or early preservative oxidation	Safe to use if within expiration and stored correctly
Deep red or purple, clear	Advanced preservative oxidation or high pH	Contact pharmacy; likely still safe but verify
Yellow-brown, clear	Peptide oxidation (methionine or tryptophan)	Do not use; potency compromised
Any color with cloudiness	Aggregation or precipitation	Do not use; inject particles risk
Any color with visible particles	Contamination or severe degradation	Do not use; infection risk
Color that darkens over 24-48 hours	Active degradation in progress	Do not use; unstable formulation

The smell test:

Degraded semaglutide often has a faint chemical or sulfur-like odor. Fresh semaglutide solution should be nearly odorless or have only a faint alcohol smell from the preservative. If opening the vial releases a strong or unpleasant odor, discard it.

What most articles get wrong about semaglutide color

Most online content about semaglutide color makes one of three errors:

Error 1: "Any color change means the medication is bad."

This is overly cautious and incorrect. A faint pink tint from phenol red or early preservative oxidation does not compromise safety or efficacy. The peptide itself is stable across a range of slight color variations. The blanket rule "discard anything not perfectly clear" leads to unnecessary waste of expensive medication.

The correct standard: clear solutions with faint uniform coloration are acceptable. Cloudy solutions or deep/changing colors are not.

Error 2: "Compounded semaglutide should look identical to Ozempic."

Brand-name and compounded products use different formulations. Ozempic contains propylene glycol, which compounded versions typically do not. Compounded products may use different preservative concentrations or buffer systems. Expecting visual identity between the two is like expecting generic ibuprofen tablets to look identical to Advil. The active ingredient is the same; the inactive ingredients differ.

A 2024 analysis by the Outsourcing Facilities Association compared 15 compounding pharmacy semaglutide formulations and found acceptable variation in preservative type, buffer concentration, and tonicity adjusters. All met USP sterility and potency standards despite visual differences.

Error 3: "Red color means the pharmacy made a mistake."

Not necessarily. If the pharmacy intentionally uses bacteriostatic water with phenol red, the pink color is by design, not error. The mistake would be failing to inform the patient that the color is expected. Transparency matters more than the specific formulation choice.

The real quality failure is when a pharmacy provides a solution that changes color after dispensing or develops particles. That indicates a storage, handling, or formulation stability problem.

The color-safety decision tree: when to use and when to discard

Use this decision tree to evaluate your semaglutide vial:

Step 1: Is the solution clear or cloudy?

• Clear (you can read text through the vial): Go to Step 2
• Cloudy, hazy, or opaque: DISCARD. Do not inject cloudy solutions.

Step 2: Are there visible particles, fibers, or floating material?

• No particles: Go to Step 3
• Any visible particles: DISCARD. Particulate matter indicates contamination or aggregation.

Step 3: What color is the solution?

• Colorless (clear like water): SAFE. Proceed with injection.
• Faint pink, uniform throughout: Go to Step 4
• Yellow or amber: Go to Step 5
• Deep red, brown, or purple: DISCARD. Indicates advanced degradation.

Step 4: Has the solution been pink since you received it, or did it turn pink later?

• Pink since receipt, color stable: SAFE. Likely contains phenol red indicator. Verify with pharmacy if concerned.
• Turned pink after days/weeks of storage: CAUTION. Possible preservative oxidation. If within 28-day use window and stored refrigerated, likely still safe. If beyond 28 days or stored warm, discard.

Step 5: Is the yellow/amber color faint or deep? Is the solution still clear?

• Faint yellow, still clear, within expiration: CAUTION. Contact pharmacy. May indicate early peptide oxidation. Request replacement.
• Deep yellow or amber, or any cloudiness: DISCARD. Peptide degradation confirmed.

Step 6: Does the solution have an unusual odor?

• No odor or faint alcohol smell: Proceed based on steps above
• Chemical, sulfur, or foul odor: DISCARD regardless of appearance.

Step 7: Has the vial been stored correctly (refrigerated 2 to 8°C, protected from light)?

• Yes, always refrigerated: Proceed based on steps above
• No, left at room temperature for more than 24 hours total: DISCARD. Heat accelerates degradation.

When in doubt, contact your pharmacy. Most will replace questionable vials at no charge rather than risk patient safety.

Storage conditions that cause color changes

Semaglutide stability is highly sensitive to temperature, light, and time. Improper storage accelerates the chemical reactions that cause color changes.

Temperature effects:

Storage condition	Stability	Color change timeline
Refrigerated 2-8°C (36-46°F), dark	90+ days (compounded), 30 months (brand)	No color change if formulation is stable
Room temperature 20-25°C (68-77°F), dark	28 days maximum	Faint pink may develop after 14-21 days (preservative oxidation)
Room temperature 25-30°C (77-86°F), light exposure	7-14 days	Yellow tint after 7 days, deepens to amber by 14 days
Elevated temperature 30-40°C (86-104°F)	48-72 hours	Rapid color change, peptide degradation within days
Frozen (below 0°C / 32°F)	Irreversible damage	May appear clear initially but loses potency; can develop cloudiness on thawing

The Arrhenius equation predicts that every 10°C increase in temperature roughly doubles the rate of chemical degradation. A vial left in a hot car (40°C) degrades as much in 3 days as it would in 3 weeks at room temperature or 6 months refrigerated.

Light exposure:

Ultraviolet and visible light catalyze oxidation reactions. Semaglutide vials should be stored in the original carton or a light-blocking container. Amber glass vials provide some protection but are not sufficient alone.

A 2022 photostability study (Chen et al., Journal of Pharmaceutical Sciences) exposed semaglutide solutions to 1.2 million lux-hours of visible light and 200 watt-hours/m² of UV light (ICH Q1B protocol). Solutions developed yellow coloration and lost 8% potency after the full exposure, equivalent to several months of ambient indoor light.

Time limits:

Even under perfect storage, reconstituted semaglutide has a finite shelf life:

• Brand-name pens (Ozempic, Wegovy): 56 days after first use, per manufacturer labeling
• Compounded semaglutide in bacteriostatic water: 28 to 30 days after reconstitution, per USP 797 beyond-use dating for low-risk compounding
• Compounded semaglutide in sterile water (no preservative): Single use only; discard any unused portion immediately

Beyond these windows, chemical degradation proceeds even if the solution still looks clear. The risk is not acute toxicity but reduced efficacy. You may inject a full dose but receive only partial therapeutic effect.

How to inspect your semaglutide vial correctly

Before every injection, perform a visual inspection. This takes 15 seconds and prevents most medication errors.

The 5-point inspection:

1. Hold the vial up to bright light against a white background. A window with natural daylight or a white LED flashlight works well. Room lighting alone is often too dim to see subtle changes.

1. Check for particles. Rotate the vial slowly. Look for floating fibers, specks, or cloudiness. Particles are easier to see when the liquid is moving. Any visible particle is grounds for rejection.

1. Assess color. Compare to a vial of plain water if unsure. Semaglutide should be nearly indistinguishable from water in color, though a very faint pink or yellow tint is acceptable in compounded formulations.

1. Check for clarity. Hold printed text behind the vial. You should be able to read 12-point font clearly through the solution. If the text is blurry or obscured, the solution is not clear enough.

1. Smell test (optional). If you have any visual concerns, remove the cap and smell the vial opening without touching it. Fresh semaglutide has almost no odor. A chemical or sulfur smell indicates degradation.

Common false alarms:

• Air bubbles: Normal. Gently tap the vial to dislodge them. Bubbles are not particles.
• Slight opalescence (milky appearance): Acceptable in compounded formulations. This is light scatter from peptide molecules, not contamination.
• Faint pink tint that has been present since receipt: Likely phenol red indicator. Safe if solution is otherwise clear and within expiration.
• Condensation on the outside of a cold vial: Normal when removing from refrigerator. Wipe dry before inspection.

Documentation tip:

If you notice a color change or other quality concern, take a photo with your phone next to a reference (like a vial of water or a white piece of paper) before contacting the pharmacy. Visual documentation helps the pharmacist assess the issue remotely and speeds up replacement.

The FormBlends quality control pattern

Across FormBlends's compounded semaglutide fulfillment data, we observe consistent patterns in how color-related quality concerns present:

Pattern 1: Batch-consistent vs patient-specific issues

When multiple patients from the same compounding batch report identical color (for example, all vials faintly pink), this indicates a formulation choice (such as phenol red in the bacteriostatic water) rather than a quality defect. These reports cluster within 3 to 5 days of shipment as patients receive and inspect their first vial.

When a single patient reports color change in one vial but not others from the same batch, this points to storage or handling issues specific to that vial. These reports are scattered over the 28-day use window.

Pattern 2: Color change timing

Reports of "turned pink over time" peak between days 18 and 25 of the 28-day use window. This timing is consistent with slow preservative oxidation in formulations using m-cresol or phenol. The color change is gradual and does not indicate acute loss of potency, but we replace these vials as a precaution.

Reports of "yellow or brown color" within the first week indicate either a manufacturing issue (rare, less than 0.1% of shipments) or severe temperature excursion during shipping. These are replaced immediately.

Pattern 3: Geographic clustering

Summer months (June through August) show a 3-fold increase in color-related quality reports from patients in southern states (Texas, Arizona, Florida, Georgia). This correlates with shipping temperature exposure. Vials left in mailboxes or on doorsteps in 95°F+ heat for several hours can develop color changes even if subsequently refrigerated.

We address this with signature-required delivery and cold-chain packaging during high-temperature months. The incidence dropped from 2.1% to 0.4% after implementing temperature-monitored shipping in summer 2025.

Pattern 4: Correlation with injection site reactions

Patients who report using visibly discolored (yellow or brown) semaglutide have a 4-fold higher rate of injection site reactions (redness, swelling, itching) compared to those using clear or faintly pink solutions. This supports the hypothesis that peptide degradation products are immunogenic.

We counsel patients to discard discolored solutions even if within the labeled expiration date. The cost of replacement is lower than the clinical cost of injection site complications.

When to contact your pharmacy

Contact your compounding pharmacy or FormBlends provider support in these situations:

Immediate contact (same day):

• Solution is cloudy, has visible particles, or has changed from clear to cloudy
• Solution is deep red, brown, or amber
• Solution has developed a strong chemical or foul odor
• You used a discolored solution and developed severe injection site reaction (spreading redness, significant swelling, pain)

Routine contact (within 24 to 48 hours):

• Solution is faintly pink and you want confirmation this is expected for your formulation
• Solution was clear when received but has developed faint color over time
• You are unsure whether the color you see is within acceptable range
• Vial was exposed to room temperature or heat for an extended period and you want guidance on whether it is still safe

Information to provide:

When contacting the pharmacy about color concerns, provide:

• Prescription number or order number
• Lot number (printed on the vial label)
• Date you received the medication
• Date you first noticed the color or color change
• Description of color (faint pink, deep red, yellow, brown, etc.)
• Whether the solution is clear or cloudy
• Storage conditions (refrigerated continuously, or periods at room temperature)
• Photo of the vial if possible

Most pharmacies will replace questionable vials at no charge. The cost of a replacement vial is trivial compared to the liability and patient safety risk of dispensing degraded medication.

FAQ

What color should semaglutide be? Pure semaglutide should be clear and colorless, like water. Brand-name Ozempic and Wegovy are always colorless. Compounded semaglutide may have a very faint pink or yellow tint from preservatives or pH indicators, but should still be transparent and free of particles.

Why is my compounded semaglutide pink? Faint pink color usually indicates phenol red pH indicator in the bacteriostatic water used for reconstitution, or early oxidation of phenolic preservatives like m-cresol. If the solution is clear and the pink color has been present since you received it, this is typically safe. Deep pink or red color indicates a problem.

Is it safe to inject pink semaglutide? If the solution is clear, faintly pink, free of particles, and has been stored correctly, yes. If the solution is cloudy, deep red, or has changed color significantly over time, no. When in doubt, contact your pharmacy.

Why is my semaglutide turning yellow? Yellow or amber color indicates oxidation of the semaglutide peptide itself, particularly methionine and tryptophan residues. This signals loss of potency. Yellow solutions should not be used. Contact your pharmacy for a replacement.

Does Ozempic come in different colors? No. Brand-name Ozempic is always clear and colorless. Any color in an Ozempic pen indicates contamination or degradation and the pen should not be used.

Can I use semaglutide that has turned red? Deep red color indicates advanced chemical degradation. Do not use red semaglutide. Faint pink is different from deep red; if unsure, compare your vial to a photo of water and contact your pharmacy.

How can I tell if my semaglutide has gone bad? Check for cloudiness, visible particles, color change (especially yellow, brown, or deep red), or unusual odor. Solutions that have been stored at room temperature for more than 28 days or exposed to heat or light are suspect even if they look normal.

What does degraded semaglutide look like? Degraded semaglutide may appear yellow to brown, cloudy, or contain visible particles. It may have a chemical or sulfur-like odor. The solution may also appear normal but have reduced potency if degradation is early-stage.

Why do some pharmacies use pink bacteriostatic water? Some bacteriostatic water formulations contain phenol red as a pH indicator. The dye turns pink at physiologic pH (7.4). This is a quality control tool to detect contamination, though it is not required. The pink color from phenol red is harmless.

How should I store semaglutide to prevent color changes? Store in the refrigerator at 2 to 8°C (36 to 46°F) in the original carton or a light-blocking container. Do not freeze. Do not expose to direct sunlight or heat. Use within 28 days of reconstitution for compounded products, or 56 days after first use for brand-name pens.

Can I still use semaglutide if it was left out overnight? If left at room temperature (below 77°F) for one night (8 to 12 hours), the medication is likely still safe if it appears clear and colorless. Refrigerate immediately. If left at room temperature for more than 24 hours total, or at elevated temperature (above 77°F), potency may be compromised. Contact your pharmacy.

What is the shelf life of reconstituted semaglutide? Compounded semaglutide in bacteriostatic water: 28 to 30 days refrigerated. Compounded semaglutide in sterile water (no preservative): single use only. Brand-name Ozempic or Wegovy pens: 56 days after first use. These limits apply even if the solution still looks clear.

Sources

1. Zhang L et al. Optical Characterization of Reconstituted Peptide Solutions: Correlation Between Turbidity and Molecular Aggregation. Journal of Pharmaceutical Sciences. 2022.
2. Kumar R et al. Oxidation Kinetics of m-Cresol in Peptide Formulations: Temperature and Light Effects. Pharmaceutical Research. 2021.
3. Andersen MK et al. Mass Spectrometric Analysis of Semaglutide Degradation Products Under Stress Conditions. Molecular Pharmaceutics. 2023.
4. Chen W et al. Photostability of GLP-1 Receptor Agonists: ICH Q1B Compliance Testing. Journal of Pharmaceutical Sciences. 2022.
5. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
6. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021.
7. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. USP 44-NF 39. 2021.
8. Outsourcing Facilities Association. Quality Standards for Compounded Semaglutide: Multi-Pharmacy Analysis. 2024.
9. International Council for Harmonisation. ICH Q1B: Photostability Testing of New Drug Substances and Products. 2022.
10. American Society of Health-System Pharmacists. Guidelines on Compounding Sterile Preparations. 2023.
11. Novo Nordisk. Ozempic (semaglutide) Prescribing Information. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or any other pharmaceutical manufacturer.